SweDeliver
Research forum in drug delivery, focusing on new strategies for parenteral, oral and pulmonary drug delivery.
News
- Center Director Christel Bergström: From a very productive spring to an equally exciting autumn 2022-06-27
- Faculty of Pharmacy at the top of international rankings 2022-06-21
- The Faculty of Pharmacy ready for ULLA Summer School 22 2022-06-21
- In focus: Maryam Tofiq keeps all professional possibilities open 2022-06-21
- Many new publications by SweDeliver's junior researchers 2022-06-21
Seminars & Events
PhD student Profile
Maryam Tofiq
"Keeping all professional possibilities open"
New PhD Thesis
Yassir Al-Tikriti
Microgels as drug delivery vehicles: Loading and release of amph. drugs
Researcher Profile
Ilse Dubbelboer
"Being part of SweDeliver means operating within a larger context"
Summer internship 22
Meet Sunniva Lin
"This completely unique opportunity is an important step to me"
This is SweDeliver
SweDeliver is a world leading research and competence centre in Drug Delivery. Many novel molecules in the drug discovery and development pipeline are biological compounds such as proteins, peptides and RNA. These display problems of poor solubility, membrane permeability and low bioavailability. Thus, the Drug Delivery area is today facing tremendous challenges to develop new drug therapies.
SweDeliver was established in response to these challenges. Based on a multi-disciplinary collaboration between academia and industry with financial support from Vinnova (Sweden’s Innovation Agency), the Faculty of Pharmacy at Uppsala University is the academic hub of the Centre with 16 industrial partners contributing expertise and research infrastructure as well as industrial perspectives and needs within the three main research areas of the Centre.
SweDeliver has prioritized to focus on outstanding research challenges within
- Parenteral Drug Delivery
- Oral Drug Delivery
- Pulmonary Drug Delivery
The research will ultimately lead to development of new and improved drug therapies with respect to both efficacy and patient safety. The Centre will also further support the strong research environment and the drug delivery ecosystem in the Nordic region.
